AI assistant
Sending…
Gentrack Group Limited — Director's Dealing 2021
Nov 8, 2021
66207_rns_2021-11-09_1442ee21-41bf-4851-80d1-85428c22e003.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [103 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 |
||
|---|---|---|
| ToNZX Limited; and | ||
| Name of listed issuer: | Gentrack GroupLimited(GTK) | |
| Date this disclosure made: | 8/11/2021 | |
| Date of last disclosure: | 2/11/2021 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | GaryKeith Miles | |
| Name of listed issuer: | Gentrack GroupLimited(GTK) | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | ManagingDirector | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | OrdinaryShares | |
| Nature of the affected relevant interest(s): | Registered Holder | |
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 1,135,708 | |
| Number held in class after acquisition or disposal: | 797,829 | |
| Current registered holder(s): | GaryKeith Miles | |
| Registered holder(s) once transfers are registered: | Not known(on market disposal) | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | Not applicable | |
| Class of underlyingfinancialproducts: | Not applicable | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying | ||
| financialproducts(if any): | Not applicable | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | Not applicable | |
| Maturitydate of the derivative(if any): | Not applicable | |
| Expirydate of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | Not applicable | |
| _For that derivative,- _ | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the | ||
| relevant interest in the derivative: | Not applicable | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 3 |
Details of transactions requiring disclosure-
| Details of transactions requiring disclosure- | ||
|---|---|---|
| Date of transaction: | 2/11/2021,3/11/2021,5/11/2021 | |
| Nature of transaction: | Disposal | |
| Name of anyotherpartyorparties to the transaction(if known): | Not known(on-market disposal) | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$646,868.95 (average $1.9144 per share) |
|
| Number of financialproducts to which the transaction related: | 1 | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevant interests were acquired or disposed of duringa closedperiod: | Yes | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
Yes | |
| Date of the prior written clearance (if any): | 27/10/2021 | |
| Summary of other relevant interests after acquisition or disposal: Class ofquoted financialproducts: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- |
||
| Not applicable | ||
| Not applicable | ||
| Not applicable | ||
| Not applicable | ||
| Type of derivative: | Not applicable | |
| ~~Details of derivative-~~ | ||
| ~~,~~ The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative (if any): | Not applicable | |
| The price's specified terms (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
Not applicable | |
| For that derivative relevant interest,- | Not applicable | |
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Certification I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorisedperson: |
||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 8/11/2021 | |
| Name and title of authorisedperson: | PipWhite, CompanySecretary | |
More from Gentrack Group Limited
Director's Dealing
2026
May 29
Director's Dealing
2026
May 25
Report Publication Announcement
2026
May 18
M&A Activity
2026
May 17
Earnings Release
2026
May 17
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
May 8
Regulatory Filings
2026
May 7
Investor Presentation
2026
May 5
Report Publication Announcement
2026
May 4